Blog

In this final TI Blog post of 2025 we acknowledge people around the world who contributed to the work of the Therapeutics Initiative in the second half of 2025. An alphabetical list is included below....

We are excited to announce that today, we posted Therapeutics Letter 159, a detailed re-evaluation of how the single enantiomer escitalopram (Cipralex, Lexapro) compares with its parent drug, citalopram (Celexa). In 2002 we first reported...

We are excited to announce that registration is now open for the 2025 annual TI Course: Bringing Best Evidence to Clinicians, happening November 28-29, 2025. The course will be offered as a virtual/online event and features a...

Today we post Therapeutics Letter 157 (July 2025): How to stop antidepressants. This complements our recent Therapeutics Letter 156 (June 2025): Antidepressant withdrawal syndrome – Update, by reviewing why stopping an antidepressant is often wise...